# OnCo record y-mabs (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/y-mabs/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "y-mabs" ;
  schema:name "Y-mAbs Therapeutics"@en ;
  schema:description "MSK spin-out that commercialises naxitamab, the humanised anti-GD2 antibody for relapsed neuroblastoma, and develops pretargeted radioimmunotherapy."@en ;
  schema:url <https://onco.cc/companies/y-mabs/>, <https://www.ymabs.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.ymabs.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/radiopharma/> ;
  onco:targets <https://onco.cc/targets/gd2/> ;
  onco:drugs <https://onco.cc/drugs/naxitamab/> .